中国高LDL-C归因心血管负担2010至2030年时空模式与情景预测
该研究基于3项全国和省级代表性调查共644,189名成人数据,采用比较风险评估量化2010至2020年中国高LDL-C归因死亡和寿命损失,并用分解分析和比例变化模型预测2030年5种控制情景。2020年归因死亡813.53千例,年龄标化归因死亡率2010至2020年上升34.41%,若趋势持续2030年将升至155.52/10万,仅LDL-C降低至少10%才能实现归因死亡率下降。
要点
- 2020年中国≥25岁成人年龄标化LDL-C为112.33 mg/dL(2.91 mmol/L)。
- 2010至2020年高LDL-C归因死亡数增加94.02%,年龄标化死亡率增加34.41%。
- 仅LDL-C降低至少10%的情景可使2030年归因死亡率较2020年下降。
核心结论
- 高LDL-C仍是中国重大公共卫生挑战,归因死亡负担快速上升,亟需全民LDL-C控制和扩大他汀治疗覆盖。
研究设计与样本
- 基于644,189名成人的3项全国和省级代表性调查的人群研究,采用比较风险评估量化2010至2020年高LDL-C归因死亡和寿命损失,并按年龄、性别和地区分层。
- 使用分解分析评估归因死亡变化的驱动因素,并用比例变化模型预测2030年5种LDL-C控制情景下的归因死亡率。
- 5种情景为自然趋势、停止上升、降低10%、降低20%和他汀治疗改善。
主要发现
- 2020年≥25岁成人年龄标化LDL-C为112.33 mg/dL(95% UI:99.97-124.68 mg/dL),即2.91 mmol/L(95% UI:2.59-3.23 mmol/L)。
- 2020年高LDL-C归因死亡为813.53千例(95% UI:774.81-860.30千例),归因寿命损失为16,108.31千人年(95% UI:15,612.47-16,685.53千人年)。
- 2010至2020年高LDL-C年龄标化归因死亡率增加34.41%,归因死亡数增加94.02%,与LDL-C水平升高、人口增长和人口老龄化相关。
- 若LDL-C趋势持续,归因死亡率将从2020年的79.97/10万(95% UI:76.16-84.57/10万)升至2030年的155.52/10万(95% UI:141.73-174.65/10万)。
- 仅LDL-C较2020年降低至少10%的情景可在2030年实现归因死亡率下降。
临床怎么用
- 应推动全民LDL-C控制并扩大他汀治疗的国家覆盖,以遏制归因死亡负担上升。
- 需将LDL-C降低至少10%作为2030年实现归因死亡率下降的最低控制目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have quantified the burden attributable to high low-density lipoprotein cholesterol (LDL-C) globally or in high-income countries. However, the disease burden of high LDL-C in China has not been fully elucidated. OBJECTIVES: The purpose of this study was to systematically evaluate the disease burden attributable to high LDL-C in China from 2010 to 2020, with projections to 2030. METHODS: In this population-based study, data were obtained from 644,189 adults across 3 large-scale, nationally and provincially representative surveys. A comparative risk assessment approach was used to quantify deaths and years of life lost attributable to high LDL-C in China from 2010 to 2020, stratified by age, sex, and region. The drivers of changes in attributable deaths were assessed using decomposition analysis. Furthermore, a proportional change model was used to estimate projections to 2030 under 5 LDL-C control scenarios: natural scenario, halting the increase, 10% reduction, 20% reduction, and statin treatment improvement. RESULTS: In 2020, the nationally age-standardized LDL-C level among adults aged ≥25 years was 112.33 mg/dL (95% uncertainty interval (UI): 99.97-124.68 mg/dL), equivalent to 2.91 mmol/L (95% UI: 2.59-3.23 mmol/L). We estimated that the number of deaths and years of life lost attributable to high LDL-C were 813.53 thousand (95% UI: 774.81-860.30 thousand) and 16,108.31 thousand (95% UI: 15,612.47-16,685.53 thousand) in 2020. Between 2010 and 2020, the age-standardized mortality rate attributable to high LDL-C increased by 34.41%, while number of deaths increased by 94.02%. This dramatic increase was closely associated with increasing LDL-C levels, population growth, and population ageing during the last 10 years. If current trends in LDL-C levels continue, the attributable mortality rate is projected to increase from 79.97 per 100,000 people (95% UI: 76.16-84.57 per 100,000 people) in 2020 to 155.52 per 100,000 people (95% UI: 141.73-174.65 per 100,000 people) by 2030. Only a reduction of at least 10% in LDL-C levels by 2030, compared with 2020 levels, would achieve a decrease in attributable mortality rate by 2030. CONCLUSIONS: High LDL-C remains a considerable public health challenge in China. The rapid increase in its attributable mortality burden underscores the urgent need for population-wide LDL-C control and expanded national coverage of statin treatment.
引用
- Tian Y, Cao X, Wang X, et al. LDL-C-Related Cardiovascular Burden in China 2010 to 2030: Spatiotemporal Patterns and Scenario-Based Projections. J Am Coll Cardiol. 2025. PMID: 41236453. doi:10.1016/j.jacc.2025.09.1592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。